Arvinas, Inc. (ARVN)
13.27
-0.11
(-0.82%)
USD |
NASDAQ |
Feb 27, 16:00
13.28
0.00 (0.00%)
After-Hours: 20:00
Arvinas Research and Development Expense (TTM) : 282.90M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Orthofix Medical, Inc. | 65.85M |
| Pfizer Inc. | 10.32B |
| Apellis Pharmaceuticals, Inc. | 295.85M |
| Elanco Animal Health, Inc. | 368.00M |
| Gossamer Bio, Inc. | 161.14M |